Pallas Health Cost 2026: Semaglutide, Tirzepatide, Billing, and Refunds

Quick answer: How much does Pallas Health cost?

As of September 10, 2026, Pallas Health’s primary GLP-1 page lists these quarterly compounded plans:

• Compounded semaglutide: $597 every 12 weeks, which Pallas labels a $199/month average.
• Compounded tirzepatide: $897 every 12 weeks, labeled a $299/month average.

Pallas says nothing is charged at checkout for new purchases under its current flow. The selected plan is charged only if a licensed clinician prescribes it.

The company also says longer plans can reduce the displayed monthly average and currently advertises semaglutide from $159/month on an annual plan, but the primary GLP-1 page we reviewed does not show the full price ladder or total annual charge for every option. That total should be verified at checkout rather than inferred.

Affiliate disclosure: Care Path Compare may receive compensation if you use a Pallas Health link and make a qualifying purchase, at no extra cost to you. Compensation does not determine our editorial conclusions.

Pallas Health pricing at a glance

Prices and policies were rechecked September 10, 2026 and may change.

Why the 12-week charge matters more than the monthly average

A price such as “$199 per month average” is useful shorthand, but it is not the same as paying $199 on the same calendar date every month.

Pallas’s current quarterly semaglutide plan is $597 every 12 weeks. Tirzepatide is $897 every 12 weeks. Those are the actual plan-cycle amounts described on the primary page.

Because 12 weeks is shorter than three calendar months, consumers comparing providers should use the full plan charge and renewal cadence rather than multiply a monthly average by an assumed number of calendar months.

A fair comparison asks:

How much is charged today? When is the next charge? What period does that payment cover?

Pallas compounded semaglutide cost

The current quarterly compounded-semaglutide plan is $597 every 12 weeks. Pallas describes that as a $199/month average.

The same page says longer plans lower the monthly average and gives $159/month as the current starting average for an annual semaglutide plan. We did not find the full annual charge published on the main GLP-1 page reviewed, so Care Path Compare would not calculate an annual total from that figure without seeing the actual checkout terms.

Before selecting a longer plan, verify:

• Total charge for the entire plan cycle.
• Whether payment is collected all at once or under a pay-over-time arrangement.
• Number and timing of pharmacy shipments.
• Renewal date and renewal amount.
• Whether the selected price is promotional.
• What happens to the current-cycle payment if treatment changes after prescribing.

Pallas compounded tirzepatide cost

Pallas’s primary page currently lists compounded tirzepatide at $897 every 12 weeks, described as a $299/month average.

The company says the compounded-plan price remains flat across dose changes, but treatment and dosing remain clinician decisions. Consumers should confirm that the displayed plan price applies to their actual checkout and state before treating it as fixed.

The same rule applies here: the $299 figure is a monthly average. The consumer-facing charge described for the quarterly plan is $897 per 12-week cycle.

What is included in Pallas’s compounded-plan price?

Pallas says its current compounded GLP-1 plan price includes:

• Licensed-clinician review.
• Ongoing check-ins.
• Dose-adjustment support.
• Care-team messaging.
• Compounded medication if prescribed.
• Shipping from a partner pharmacy.

The primary page says there is no separate membership fee and no per-visit charge for the bundled compounded plan.

Laboratory testing is less clear. The public materials we reviewed do not provide one universal rule for whether labs are required for every patient or whether every possible test is included. Ask about labs before comparing Pallas’s bundled price with another provider’s advertised rate.

When does Pallas charge your card?

Pallas changed this process in September.

Its Terms state that plans purchased on or after September 8, 2026 save the payment method at checkout but do not immediately charge it. If a licensed clinician prescribes the selected plan, the plan-cycle price is charged then.

If the clinician does not prescribe, Pallas says no charge is made. If the user cancels before the clinical decision, the current Terms also say nothing is charged.

This is materially different from providers that capture the full subscription payment before clinical review.

Consumers who purchased before September 8 may have legacy deposit terms and should refer to their original agreement.

How Pallas renewals work

The current Terms say the subscription renews at the same selected plan price every billing period, anchored to the prescription date, subject to the terms shown at checkout and any properly noticed future price change.

Pallas describes multiple possible billing periods—monthly, quarterly, six-month, and annual—but its primary GLP-1 page currently foregrounds the 12-week quarterly option and mentions lower averages on longer plans without publishing the complete ladder.

Before payment, save or screenshot:

• The billing period.
• Total charge.
• Prescription/initial charge date.
• Next renewal date.
• Renewal amount.
• Cancellation instructions.

That information is more reliable for budgeting than a monthly-average headline.

Pallas brand-name GLP-1 cash prices

Pallas also advertises FDA-approved brand-name products on a cash-pay basis. Current public prices on the GLP-1 page include:

• Zepbound: $1,069/month cash-pay.
• Ozempic: $1,299/month cash-pay.
• Wegovy: $1,349/month cash-pay.
• Mounjaro: $1,349/month cash-pay.

Those are separate from Pallas’s compounded-plan pricing and can change with pharmacy cash-pay rates. Consumers should not compare a compounded-plan monthly average with a brand-name cash price as if they were the same product or regulatory category.

What happens if the clinician does not prescribe?

For the current post-September-8 flow, Pallas says the consumer is not charged if the clinician decides not to prescribe the selected plan.

That reduces the risk of paying the full medication-plan price before eligibility is determined. Nevertheless, the checkout page should still be reviewed carefully for any add-ons, payment-plan terms, or authorizations that apply to the selected transaction.

Can you cancel Pallas Health?

Pallas says cancellation is free and stops future billing. Under the current Terms, once a prescription has been issued, the current cycle is generally final and is not prorated or refunded merely because the consumer cancels.

That means “cancel anytime” should be understood primarily as stop future renewals, not as a promise that the current paid cycle can always be refunded.

The six-month satisfaction policy and cost risk

Pallas publishes a conditional six-month satisfaction promise. For qualifying continuously active patients who meet the participation, recordkeeping, timing, and claim conditions, the policy can allow refund of qualifying plan payments made during the six-month period.

This should be treated as a commercial refund policy, not a medical or weight-loss guarantee.

Before relying on it financially, confirm the current version of the policy and understand:

• Continuous-plan requirements.
• Required check-ins and records.
• Claim deadline.
• Which payments are covered.
• How earlier refunds interact with the claim.

What happens with a damaged shipment?

Pallas’s current policy says a damaged or compromised shipment should be reported within 24 hours of delivery. The policy describes pharmacy replacement or refund as the remedy for a qualifying damaged shipment.

Consumers should document the package condition, label, temperature/storage instructions, and contact with the pharmacy or care team promptly if there is a problem.

Questions to ask before paying Pallas Health

• What exact amount will be charged if I am prescribed the selected plan?
• Is this monthly, every 12 weeks, six months, or annual?
• What is the full plan-cycle total?
• If a monthly average is displayed, what amount actually hits my card?
• Is any promotional price temporary?
• What is my next renewal date and amount?
• Does the price include all provider visits and medication shipments?
• Are labs required, and if so, are they included?
• Which pharmacy will dispense the prescription?
• When does the current paid cycle become non-refundable?
• Do I qualify for the six-month satisfaction policy, and what are its conditions?

Bottom line

Pallas’s current pricing is relatively transparent about the actual quarterly charge: $597 every 12 weeks for compounded semaglutide and $897 every 12 weeks for compounded tirzepatide. The main thing to avoid is treating the provider’s $199 and $299 monthly averages as if they were ordinary calendar-month charges.

Pallas also advertises lower monthly averages on longer plans, but consumers should compare the full plan-cycle amount, renewal timing, refund exposure, included care, and actual pharmacy before deciding whether a longer commitment is cheaper in practice.

For the provider-level due-diligence picture, see our Pallas Health review.

Medical disclaimer: This page is for consumer education and cost comparison only. It does not provide medical advice, diagnose conditions, or determine eligibility for prescription medication. Eligibility and treatment decisions are made by licensed healthcare professionals. Compounded medications are not FDA-approved finished drug products; discuss risks, benefits, alternatives, and appropriate treatment with a licensed clinician.